DocGo

DocGo Gross Profit

The Gross Profit of DocGo (DCGO) as of Nov 7, 2026 is 98.76 M USD. In the previous year, Gross Profit was 213.57 M USD — a change of -53.76% (lower).

Gross Profit

98.76 MUSD

YoY

-53.76%

Last updated:

Gross Profit of DocGo is 2025 98.76 M USD. Gross Profit of DocGo was 2024 213.57 M USD. It decreases by -53.76% lower compared to the previous year.

The DocGo Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2019
13.19 M USD
Jan 1, 2020
31.35 M USD
Jan 1, 2021
109.75 M USD
Jan 1, 2022
154.72 M USD
Jan 1, 2023
195.38 M USD
Jan 1, 2024
213.57 M USD
Jan 1, 2025
98.76 M USD
The DocGo Gross Profit history
YEARGross ProfitYoY
98.76 MUSD-53.76%
213.57 MUSD+9.31%
195.38 MUSD+26.28%
154.72 MUSD+40.98%
109.75 MUSD+250.10%
31.35 MUSD+137.67%
13.19 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DocGo Revenue

DocGo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
318.72 M USD
16.12 M USD
23.74 M USD
Jan 1, 2022
440.52 M USD
21.83 M USD
34.58 M USD
Jan 1, 2023
624.29 M USD
15.05 M USD
6.86 M USD
Jan 1, 2024
616.56 M USD
28.69 M USD
19.99 M USD
Jan 1, 2025
322.20 M USD
-89.16 M USD
-182.40 M USD
Jan 1, 2026 (e)
306.50 M USD
-48.07 M USD
-49.64 M USD
Jan 1, 2027 (e)
325.77 M USD
11.59 M USD
-26.41 M USD
Jan 1, 2028 (e)
337.20 M USD
-30.64 M USD
-31.30 M USD

DocGo Margins

DocGo stock margins

The DocGo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocGo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocGo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
34.43 %
5.06 %
7.45 %
Jan 1, 2022
35.12 %
4.96 %
7.85 %
Jan 1, 2023
31.30 %
2.41 %
1.10 %
Jan 1, 2024
34.64 %
4.65 %
3.24 %
Jan 1, 2025
30.65 %
-27.67 %
-56.61 %
Jan 1, 2026 (e)
30.65 %
-15.68 %
-16.20 %
Jan 1, 2027 (e)
30.65 %
3.56 %
-8.11 %
Jan 1, 2028 (e)
30.65 %
-9.09 %
-9.28 %

DocGo Stock analysis

What does DocGo do? The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare. DocGo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DocGo stock

Gross Profit of DocGo is 98.76 M USD in 2025.

Gross Profit of DocGo changed from 213.57 M USD to 98.76 M USD, representing a -53.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit DocGo since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's DocGo historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — DocGo

All Key Metrics — DocGo